Skip to main content
Erschienen in: Pediatric Nephrology 3/2021

16.09.2020 | Original Article

Comparing predictive values of carbohydrate antigen 19-9, neutrophil gelatinase–associated lipocalin, and kidney injury molecule-1 in 161 patients with ureteropelvic junction obstruction

verfasst von: Kiarad Fendereski, Amirreza Nabighadim, Maryam Seyedtabib, Seyedeh Sima Daryabari, Mohammad Taghi Haghi-Ashtiani, Abdol-Mohammad Kajbafzadeh

Erschienen in: Pediatric Nephrology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

To evaluate and compare the efficacy of urinary carbohydrate antigen 19-9 (CA19-9), neutrophil gelatinase–associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1) biomarkers as predictive factors to determine the surgery requirement in patients with ureteropelvic junction obstruction.

Methods

We obtained urine samples from 161 patients at diagnosis and evaluated their levels of the three biomarkers. The patients were under observation for 2 years; subsequently, they were divided into two groups based on their requirement of pyeloplasty. We determined the correlation between the urinary concentration of the biomarkers and surgical interventions, as well as the kidney function deterioration and sonography outcomes.

Results

The non-surgery group included 60 male and 22 female patients with mean age of 21 months. The surgery group comprised 58 boys and 21 girls with mean age of 26.9 months with no significant difference of age and gender between the two groups. The outcomes were indicative of higher efficacy of CA19-9 level with a sensitivity and specificity of 84.2% and 73.2% at the cutoff point of 59.09 U/ml. Also, a significant negative correlation was detected between the kidney function and the concentrations of CA19-9 and NGAL.

Conclusions

Our evaluations demonstrate the higher efficacy of CA19-9 to predict the requirement of surgical intervention in comparison with the other biomarkers, as well as a significant correlation between kidney function deterioration and urinary CA19-9 and NGAL. The outcomes of this investigation could pave the way for more extensive clinical application of these urinary biomarkers, besides future research determining the association between markers and kidney fibrosis.
Literatur
1.
Zurück zum Zitat Nguyen HT, Herndon CA, Cooper C, Gatti J, Kirsch A, Kokorowski P, Lee R, Perez-Brayfield M, Metcalfe P, Yerkes E, Cendron M, Campbell JB (2010) The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 6:212–231CrossRef Nguyen HT, Herndon CA, Cooper C, Gatti J, Kirsch A, Kokorowski P, Lee R, Perez-Brayfield M, Metcalfe P, Yerkes E, Cendron M, Campbell JB (2010) The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 6:212–231CrossRef
2.
Zurück zum Zitat Choi YH, Cheon J-E, Kim WS, Kim IO (2016) Ultrasonography of hydronephrosis in the newborn: a practical review. Ultrasonography 35:198–211CrossRef Choi YH, Cheon J-E, Kim WS, Kim IO (2016) Ultrasonography of hydronephrosis in the newborn: a practical review. Ultrasonography 35:198–211CrossRef
3.
Zurück zum Zitat Anderson NG, Fischer J, Leighton D, Hector-Taylor J, McEwing RL (2010) Management in children of mild postnatal renal dilatation but without vesicoureteral reflux. Pediatr Nephrol 25:477–483CrossRef Anderson NG, Fischer J, Leighton D, Hector-Taylor J, McEwing RL (2010) Management in children of mild postnatal renal dilatation but without vesicoureteral reflux. Pediatr Nephrol 25:477–483CrossRef
4.
Zurück zum Zitat Chevalier RL (1999) Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr Nephrol 13:612–619CrossRef Chevalier RL (1999) Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr Nephrol 13:612–619CrossRef
5.
Zurück zum Zitat Madsen MG, Nørregaard R, Frøkiær J, Jørgensen TM (2011) Urinary biomarkers in prenatally diagnosed unilateral hydronephrosis. J Pediatr Urol 7:105–112CrossRef Madsen MG, Nørregaard R, Frøkiær J, Jørgensen TM (2011) Urinary biomarkers in prenatally diagnosed unilateral hydronephrosis. J Pediatr Urol 7:105–112CrossRef
6.
Zurück zum Zitat Karakus S, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Atar A, Ander H, Ziylan O (2016) Urinary IP-10, MCP-1, NGAL, cystatin-C, and KIM-1 levels in prenatally diagnosed unilateral hydronephrosis: the search for an ideal biomarker. Urology 87:185–192CrossRef Karakus S, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Atar A, Ander H, Ziylan O (2016) Urinary IP-10, MCP-1, NGAL, cystatin-C, and KIM-1 levels in prenatally diagnosed unilateral hydronephrosis: the search for an ideal biomarker. Urology 87:185–192CrossRef
7.
Zurück zum Zitat Clermont MJ, Brion LP, Schwartz GJ (1986) Reliability of plasma creatinine measurement in infants and children. Clin Pediatr 25:569–572CrossRef Clermont MJ, Brion LP, Schwartz GJ (1986) Reliability of plasma creatinine measurement in infants and children. Clin Pediatr 25:569–572CrossRef
8.
Zurück zum Zitat Chevalier RL (2016) Prognostic factors and biomarkers of congenital obstructive nephropathy. Pediatr Nephrol 31:1411–1420CrossRef Chevalier RL (2016) Prognostic factors and biomarkers of congenital obstructive nephropathy. Pediatr Nephrol 31:1411–1420CrossRef
9.
Zurück zum Zitat Mandell J, Peters CA, Estroff JA, Allred EN, Benacerraf BR (1993) Human fetal compensatory renal growth. J Urol 150:790–792CrossRef Mandell J, Peters CA, Estroff JA, Allred EN, Benacerraf BR (1993) Human fetal compensatory renal growth. J Urol 150:790–792CrossRef
11.
Zurück zum Zitat Taylor AT (2014) Radionuclides in nephrourology, part 2: pitfalls and diagnostic applications. J Nucl Med 55:786–798CrossRef Taylor AT (2014) Radionuclides in nephrourology, part 2: pitfalls and diagnostic applications. J Nucl Med 55:786–798CrossRef
12.
Zurück zum Zitat Eskild-Jensen A, Gordon I, Piepsz A, Frøkiaer J (2004) Interpretation of the renogram: problems and pitfalls in hydronephrosis in children. BJU Int 94:887–892CrossRef Eskild-Jensen A, Gordon I, Piepsz A, Frøkiaer J (2004) Interpretation of the renogram: problems and pitfalls in hydronephrosis in children. BJU Int 94:887–892CrossRef
13.
Zurück zum Zitat Kajbafzadeh AM, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P (2010) Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. J Urol 183:2353–2360CrossRef Kajbafzadeh AM, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P (2010) Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. J Urol 183:2353–2360CrossRef
14.
Zurück zum Zitat Wasilewska A, Taranta-Janusz K, Dębek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E (2011) KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol 26:579–586CrossRef Wasilewska A, Taranta-Janusz K, Dębek W, Zoch-Zwierz W, Kuroczycka-Saniutycz E (2011) KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol 26:579–586CrossRef
15.
Zurück zum Zitat Cost NG, Noh PH, Devarajan P, Ivancic V, Reddy PP, Minevich E, Bennett M, Haffner C, Schulte M, DeFoor WR Jr (2013) Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty. J Urol 190:1462–1467CrossRef Cost NG, Noh PH, Devarajan P, Ivancic V, Reddy PP, Minevich E, Bennett M, Haffner C, Schulte M, DeFoor WR Jr (2013) Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty. J Urol 190:1462–1467CrossRef
16.
Zurück zum Zitat Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE (2015) Definitive characterization of CA 19-9 in resectable pancreatic cancer using a reference set of serum and plasma specimens. PLoS One 10:e0139049CrossRef Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE (2015) Definitive characterization of CA 19-9 in resectable pancreatic cancer using a reference set of serum and plasma specimens. PLoS One 10:e0139049CrossRef
17.
Zurück zum Zitat Atar A, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Ander H, Ziylan O, Kadioglu TC (2015) The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis. J Pediatr Urol 11(133):e1–e5 Atar A, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Ander H, Ziylan O, Kadioglu TC (2015) The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis. J Pediatr Urol 11(133):e1–e5
19.
Zurück zum Zitat Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534–2543CrossRef Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534–2543CrossRef
20.
Zurück zum Zitat Bonventre JV (2009) Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24:3265–3268CrossRef Bonventre JV (2009) Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24:3265–3268CrossRef
21.
Zurück zum Zitat Mohammadjafari H, Rafiei A, Kosaryan M, Yeganeh Y, Hosseinimehr SJ (2014) Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels. Biomark Med 8:1199–1206CrossRef Mohammadjafari H, Rafiei A, Kosaryan M, Yeganeh Y, Hosseinimehr SJ (2014) Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels. Biomark Med 8:1199–1206CrossRef
22.
Zurück zum Zitat Hajian-Tilaki K (2013) Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med 4:627–635PubMedPubMedCentral Hajian-Tilaki K (2013) Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med 4:627–635PubMedPubMedCentral
23.
Zurück zum Zitat Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, Bonventre JV, Jaber BL (2007) Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18:904–912CrossRef Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, Bonventre JV, Jaber BL (2007) Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18:904–912CrossRef
24.
Zurück zum Zitat Mårtensson J, Martling CR, Bell M (2012) Novel biomarkers of acute kidney injury and failure: clinical applicability. Br J Anaesth 109:843–850CrossRef Mårtensson J, Martling CR, Bell M (2012) Novel biomarkers of acute kidney injury and failure: clinical applicability. Br J Anaesth 109:843–850CrossRef
25.
Zurück zum Zitat Kajbafzadeh AM, Keihani S, Kameli SM, Hojjat A (2017) Maternal urinary carbohydrate antigen 19-9 as a novel biomarker for evaluating fetal hydronephrosis: a pilot study. Urology 101:90–93CrossRef Kajbafzadeh AM, Keihani S, Kameli SM, Hojjat A (2017) Maternal urinary carbohydrate antigen 19-9 as a novel biomarker for evaluating fetal hydronephrosis: a pilot study. Urology 101:90–93CrossRef
Metadaten
Titel
Comparing predictive values of carbohydrate antigen 19-9, neutrophil gelatinase–associated lipocalin, and kidney injury molecule-1 in 161 patients with ureteropelvic junction obstruction
verfasst von
Kiarad Fendereski
Amirreza Nabighadim
Maryam Seyedtabib
Seyedeh Sima Daryabari
Mohammad Taghi Haghi-Ashtiani
Abdol-Mohammad Kajbafzadeh
Publikationsdatum
16.09.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 3/2021
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-020-04750-w

Weitere Artikel der Ausgabe 3/2021

Pediatric Nephrology 3/2021 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.